Up a level |
Number of items: 1.
Zelniker, TA, Raz, I, Mosenzon, O, Dwyer, JP, Heerspink, HJL, Cahn, A, Im, K, Bhatt, DL, Leiter, LA, McGuire, DK et al (show 5 more authors)
(2019)
Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: Insights from DECLARE-TIMI 58.
.